In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.
Learn more about our policy
EN
FR
Search for:
Navigation
Services
Preclinical solutions
Clinical trials
Biomarkers solution
ELISA Kits
Home
About us
The company
The executive team
Facilities
References
Certifications
Jobs
News & Events
News & Publications
Events
Testimonials
FAQ
Contact
News & Events
>
News & Publications
>
Effect of chondroitin sulfate on soluble biomarkers of OA
This study proposes a new approach for the analysis and the interpretation of the individual variation in biomarker levels and introduces the notion of metabolic responders.
Published on 06/10/2016
Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis
Seventy two patients with unilateral symptomatic knee OA were involved in a post-authorization open-label study evaluating CS (800 mg/day). The primary outcome was the % relative change in serum Coll2-1 (sColl2-1). The secondary outcomes were the evaluation of pain (VAS) and function (Lequesne’s Index). Responders and non-responders were classified according to OMERACT-OARSI recommendations. Finally, an original cut-off method was applied to categorize patients and interpret individual variations in serum levels of Coll2-1.
PubMed
Our latest news
20/03/2020
Artialis answers the call of the CHU of Liege
01/10/2019
Review about Coll2-1 and Coll2-1NO2
Read more
News & Publications
Events
Testimonials
© Artialis - All rights reserved
Terms & conditions
-
Privacy Policy
Made by